Hologic posts healthy Q3 financials

Increased sales in all four of its businesses fueled women's imaging vendor Hologic to gains in the company's third quarter of fiscal 2016 (end-June 25).

Third-quarter revenue increased 3.4% to $717.4 million, based on constant currency, compared with sales of $693.9 million in the third quarter of fiscal 2015. Net income almost tripled to $84.8 million, compared with $29.4 million in last year's third quarter.

For the nine-month period, Hologic's revenue increased 5% to $2.1 billion, compared with $2 billion in the same period of fiscal 2015. Net income more than doubled to $238.7 million, compared with $106.5 million in the first nine months of fiscal 2015.

In the company's Breast Health business segment, revenue totaled $282.5 million, an increase of 1.1%. Revenue grew 1.9% in the U.S. with the adoption of its Genius digital breast tomosynthesis systems, despite a "difficult" comparison in the prior year period. On a global basis, Breast Health revenue declined 2.9% at constant currency rates. When sales of discontinued products were excluded, however, international Breast Health revenue increased slightly, the firm said.